DECHENG CAPITAL MANAGEMENT III (CAYMAN), LLC – Nautilus Biotechnology, Inc. Transaction History
DECHENG CAPITAL MANAGEMENT III (CAYMAN), LLC portfolio value:
$636,000
portfolio value
DECHENG CAPITAL MANAGEMENT III (CAYMAN), LLC quarter portfolio value change:
-21.19%
quarter
Nautilus Biotechnology, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -171K | $2.12 | 300K | |
| Q2 2022 | share | 0.00% | 0 shares | -495K | $2.69 | 300K | |
| Q1 2022 | share | Increase | 0.00% | 300K shares | 1.30M | $4.34 | 300K |